News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,536 Results
Type
Article (15303)
Company Profile (299)
Press Release (267928)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80128)
Career Advice (164)
Deals (13369)
Drug Delivery (40)
Drug Development (51177)
Employer Resources (31)
FDA (5890)
Job Trends (5192)
News (145838)
Policy (10177)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (955)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21912)
ALS (126)
Alzheimer's disease (1032)
Antibody-drug conjugate (ADC) (242)
Approvals (6082)
Artificial intelligence (260)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4585)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (46)
Breast cancer (345)
Cancer (3148)
Cardiovascular disease (240)
Career advice (148)
Career pathing (7)
CAR-T (220)
CDC (5)
Cell therapy (568)
Cervical cancer (14)
Clinical research (44007)
Collaboration (1153)
Company closure (2)
Compensation (592)
Complete response letters (39)
COVID-19 (1174)
CRISPR (86)
C-suite (550)
Cystic fibrosis (113)
Data (4344)
Denatured (15)
Depression (93)
Diabetes (255)
Diagnostics (1395)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (190)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (217)
Earnings (31708)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51910)
Executive appointments (621)
FDA (7646)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (980)
Gene editing (185)
Generative AI (23)
Gene therapy (503)
GLP-1 (505)
Government (1176)
Grass and pollen (3)
Guidances (167)
Healthcare (6672)
HIV (18)
Huntington's disease (43)
IgA nephropathy (75)
Immunology and inflammation (192)
Immuno-oncology (39)
Indications (66)
Infectious disease (1282)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (39)
Intellectual property (166)
Interviews (18)
IPO (7356)
IRA (12)
Job creations (869)
Job search strategy (130)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (247)
Leadership (9)
Legal (1422)
Liver cancer (41)
Longevity (11)
Lung cancer (420)
Lymphoma (250)
Machine learning (24)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2669)
Medtech (2678)
Mergers & acquisitions (6635)
Metabolic disorders (725)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (70)
Neuroscience (1957)
Neurotech (1)
NextGen: Class of 2026 (2050)
Non-profit (877)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (234)
Partnered (13)
Patents (307)
Patient recruitment (331)
Peanut (43)
People (26703)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15654)
Phase 2 (20451)
Phase 3 (12901)
Pipeline (3255)
Policy (91)
Postmarket research (855)
Preclinical (6582)
Press Release (33)
Prostate cancer (146)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (657)
Real estate (1452)
Recruiting (12)
Regulatory (9961)
Reports (19)
Research institute (992)
Resumes & cover letters (19)
Rett syndrome (26)
RNA editing (21)
RSV (21)
Schizophrenia (123)
Series A (182)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (121)
Sponsored (15)
Startups (2014)
State (1)
Stomach cancer (6)
Supply chain (33)
Tariffs (18)
The Weekly (62)
Vaccines (362)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Last 7 days (345)
Last 30 days (1155)
Last 365 days (17897)
2026 (1658)
2025 (18200)
2024 (20684)
2023 (22553)
2022 (26988)
2021 (27994)
2020 (23534)
2019 (16348)
2018 (11824)
2017 (13847)
2016 (11929)
2015 (14454)
2014 (10469)
2013 (7557)
2012 (7588)
2011 (7673)
2010 (7465)
Location
Africa (155)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18352)
Australia (3128)
California (7101)
Canada (1840)
China (775)
Colorado (246)
Connecticut (255)
Delaware (239)
Europe (39578)
Florida (904)
Georgia (215)
Hawaii (2)
Idaho (17)
Illinois (397)
India (35)
Indiana (160)
Iowa (8)
Japan (225)
Kansas (80)
Kentucky (10)
Louisiana (7)
Maine (11)
Maryland (738)
Massachusetts (5592)
Michigan (112)
Minnesota (248)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1660)
New Mexico (13)
New York (1764)
North Carolina (831)
North Dakota (6)
Northern California (3478)
Ohio (178)
Oklahoma (11)
Oregon (24)
Pennsylvania (1288)
Puerto Rico (9)
Rhode Island (25)
South America (219)
South Carolina (9)
Southern California (2822)
Tennessee (41)
Texas (913)
United States (23427)
Utah (96)
Virginia (137)
Washington D.C. (37)
Washington State (593)
West Virginia (1)
Wisconsin (45)
283,536 Results for "encoded therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Encoded Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026
January 6, 2026
·
1 min read
Press Releases
Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome
January 12, 2026
·
3 min read
Press Releases
Encoded Therapeutics Strengthens Clinical Leadership Team with Appointment of Professor Joseph Sullivan, M.D., as Vice President of Clinical Development
December 17, 2025
·
2 min read
Press Releases
Encoded Therapeutics Highlights Progress in Dravet Syndrome Program and Pipeline Ahead of Company Presentation at 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
·
5 min read
Press Releases
Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome
December 8, 2025
·
8 min read
Press Releases
New Preclinical Data from Encoded Therapeutics Demonstrate Therapeutic Potential of its One-time, Non-opioid Gene Therapy Candidate for Chronic Pain
October 10, 2025
·
4 min read
Layoffs
Encoded Cuts 29% of Workforce to Extend Cash Runway, Advance Pipeline
Encoded’s layoffs will mostly affect its technology and early-stage research and development functions. The move is expected to keep the biotech operational well into 2026.
February 13, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Encoded Therapeutics to Present Interim Phase 1/2 Clinical Data on ETX101, the First One-time Gene Therapy in Development for Dravet Syndrome, at the 2025 American Epilepsy Society Annual Meeting
December 2, 2025
·
4 min read
Press Releases
DNA-encoded Library Market Size to Hit USD 2.6 Billion by 2034
November 20, 2025
·
1 min read
Press Releases
Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome
September 2, 2025
·
5 min read
1 of 28,354
Next
